These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26038527)

  • 41. Prolonged podocyte depletion in larval zebrafish resembles mammalian focal and segmental glomerulosclerosis.
    Hansen KUI; Siegerist F; Daniel S; Schindler M; Iervolino A; Blumenthal A; Daniel C; Amann K; Zhou W; Endlich K; Endlich N
    FASEB J; 2020 Dec; 34(12):15961-15974. PubMed ID: 33070374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
    Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
    Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activated parietal epithelial cells or dedifferentiated podocytes in FSGS: can we make the difference?
    Bariéty J; Bruneval P
    Kidney Int; 2006 Jan; 69(1):194. PubMed ID: 16374444
    [No Abstract]   [Full Text] [Related]  

  • 44. Glomerular diseases: podocyte hypertrophy mismatch and glomerular disease.
    Kriz W
    Nat Rev Nephrol; 2012 Nov; 8(11):618-9. PubMed ID: 23007616
    [No Abstract]   [Full Text] [Related]  

  • 45. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
    Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
    Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. APOL1 kidney risk alleles: population genetics and disease associations.
    Limou S; Nelson GW; Kopp JB; Winkler CA
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter rats.
    Ijpelaar DH; Schulz A; Koop K; Schlesener M; Bruijn JA; Kerjaschki D; Kreutz R; de Heer E
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F758-67. PubMed ID: 18199599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Podocytes and glomerular function with aging.
    Wiggins J
    Semin Nephrol; 2009 Nov; 29(6):587-93. PubMed ID: 20006790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compound effects of aging and experimental FSGS on glomerular epithelial cells.
    Schneider RR; Eng DG; Kutz JN; Sweetwyne MT; Pippin JW; Shankland SJ
    Aging (Albany NY); 2017 Feb; 9(2):524-546. PubMed ID: 28222042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population-based risk assessment of APOL1 on renal disease.
    Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
    J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction?
    Kopp JB
    Kidney Int; 2013 Dec; 84(6):1069-72. PubMed ID: 24280748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
    Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
    J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
    Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of focal segmental glomerulosclerosis.
    Reidy K; Kaskel FJ
    Pediatr Nephrol; 2007 Mar; 22(3):350-4. PubMed ID: 17216262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
    Cook HT
    Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. APOL1 and nephropathy progression in populations of African ancestry.
    Freedman BI
    Semin Nephrol; 2013 Sep; 33(5):425-32. PubMed ID: 24119848
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Podocyte biology: Age-associated changes in podocytes linked to FGGS.
    Allison SJ
    Nat Rev Nephrol; 2015 Aug; 11(8):444. PubMed ID: 26100505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.